Choong Ang Vaccine Laboratory Balance Sheet Health
Financial Health criteria checks 0/6
Insufficient data to determine the health of Choong Ang Vaccine Laboratory
Key information
n/a
Debt to equity ratio
n/a
Debt
Interest coverage ratio | n/a |
Cash | n/a |
Equity | n/a |
Total liabilities | n/a |
Total assets | n/a |
Recent financial health updates
Here's Why Choong Ang Vaccine Laboratory (KOSDAQ:072020) Can Manage Its Debt Responsibly
Mar 08Here's Why Choong Ang Vaccine Laboratory (KOSDAQ:072020) Can Manage Its Debt Responsibly
Dec 08Recent updates
Here's Why Choong Ang Vaccine Laboratory (KOSDAQ:072020) Can Manage Its Debt Responsibly
Mar 08Here's What Choong Ang Vaccine Laboratory Co., Ltd.'s (KOSDAQ:072020) Shareholder Ownership Structure Looks Like
Feb 15The Choong Ang Vaccine Laboratory (KOSDAQ:072020) Share Price Has Gained 32% And Shareholders Are Hoping For More
Jan 19Is Choong Ang Vaccine Laboratory Co., Ltd.'s (KOSDAQ:072020) Stock Price Struggling As A Result Of Its Mixed Financials?
Dec 29Here's Why Choong Ang Vaccine Laboratory (KOSDAQ:072020) Can Manage Its Debt Responsibly
Dec 08Here's What Choong Ang Vaccine Laboratory Co., Ltd.'s (KOSDAQ:072020) Shareholder Ownership Structure Looks Like
Nov 17In this section we usually analyse Choong Ang Vaccine Laboratory's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Choong Ang Vaccine Laboratory has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.
Financial Position Analysis
Short Term Liabilities: Insufficient data to determine if A072020's short term assets cover its short term liabilities.
Long Term Liabilities: Insufficient data to determine if A072020's short term assets cover its long term liabilities.
Debt to Equity History and Analysis
Debt Level: Insufficient data to calculate A072020's net debt to equity ratio to determine if it is satisfactory.
Reducing Debt: Insufficient data to determine if A072020's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: Insufficient data to determine if A072020's debt is well covered by operating cash flow.
Interest Coverage: Insufficient data to determine if A072020's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/10 18:29 |
End of Day Share Price | 2025/01/10 00:00 |
Earnings | 2023/03/31 |
Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Choong Ang Vaccine Laboratory Co., Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Changhee Woo | IBK Securities Co. Ltd. |
Sang-Yong Jeon | LS Securities Co., Ltd. |
Tae Gi Ha | SK Securities Co., Ltd. |